{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:30:16Z","timestamp":1762475416189,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jdcr.2022.08.029","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T21:03:08Z","timestamp":1661634188000},"page":"23-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests"],"prefix":"10.1016","volume":"33","author":[{"given":"Jung Eun","family":"Seol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Woo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Yeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyojin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2022.08.029_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catal\u00e0","year":"2022","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2022.08.029_bib2","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1111\/jdv.17390","article-title":"SARS-CoV-2 mRNA vaccine-associated fixed drug eruption","volume":"35","author":"Mintoff","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jdcr.2022.08.029_bib3","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jaip.2022.03.033","article-title":"Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: a case report","volume":"10","author":"Lellig","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.jdcr.2022.08.029_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/ced.14926","article-title":"Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination","volume":"47","author":"Wantavornprasert","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2022.08.029_bib5","first-page":"e516","article-title":"Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)","volume":"36","author":"Salem","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jdcr.2022.08.029_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jiph.2021.06.021","article-title":"Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: case report","volume":"14","author":"Kong","year":"2021","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.jdcr.2022.08.029_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12111","article-title":"Allergy to polyethylene glycol and polysorbates in a patient cohort: diagnostic work-up and decision points for vaccination during the COVID-19 pandemic","volume":"12","author":"Mortz","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.jdcr.2022.08.029_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cea.14064","article-title":"The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients","volume":"52","author":"Sellaturay","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.jdcr.2022.08.029_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.jdcr.2022.08.029_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-020-00505-3","article-title":"Fixed drug eruptions: an update, emphasizing the potentially lethal generalized bullous fixed drug eruption","volume":"21","author":"Patel","year":"2020","journal-title":"Am J Clin Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262200385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262200385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:06Z","timestamp":1762475106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262200385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":10,"alternative-id":["S235251262200385X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.08.029","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}